Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    20976768 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Interventions: Drug: Fampridine-SR;   Drug: Placebo
2 Unknown  Resistance Training and Amino Pyridine in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: SR-fampridine;   Drug: Placebo
3 Recruiting Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine
4 Completed A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Condition: Non Arteritic Ischemic Optic Neuropathy
Interventions: Drug: dalfampridine;   Drug: Placebo
5 Completed FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR

Study has passed its completion date and status has not been verified in more than two years.